Cardiol Therapeutics is a binary, catalyst-driven biotech, with its investment case hinging on CardiolRx’s Phase III MAVERIC ...

Brex reports on calculating accounts payable, emphasizing the importance of accurate inputs and reconciliation for reliable ...

Company reduces the maximum aggregate payments under its royalty financing agreement from $125 million to $65 millionCompany accelerated payment of $42.6 million upfront, bringing total payments made ...

On August 13, Kodiak Sciences Inc. (NASDAQ:KOD) reported second-quarter financial results for the period ended June 30, ...

Ironwood now expects 2026 LINZESS net sales of $1.15 billion to $1.20 billion and adjusted EBITDA above $310 million. Read ...

Amgen trades at a fraction of Moderna's valuation, but one company is burning cash while the other generates billions, a ...

For most businesses, claims filed by current or former employees are inevitable. Companies, especially those with ...

Operator: Good morning, and welcome to the PAVmed second quarter 2026 Business Update conference call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the ...

Relmada Therapeutics Inc. stocks have been trading up by 12.28 percent following highly positive clinical trial progress news. What Traders Need To Know Shares climbed nearly 11% after the CEO and CFO ...

Bluejay Diagnostics Inc. stocks have been trading up by 23.74 percent amid heightened optimism from its latest clinical ...

Tenon Medical Inc. soared after positive clinical progress updates, as stocks have been trading up by 42.62 percent. Key ...

Roivant Sciences Ltd. stocks have been trading up by 20.11 percent after breakthrough clinical trial success boosted investor ...